Your shopping cart is currently empty

AChE-IN-62 (Compound 1) is a potent, mixed-type selective inhibitor of acetylcholinesterase (AChE) with an IC50 value of 0.421 μM. It effectively penetrates the blood-brain barrier and offers neuroprotective effects. Additionally, AChE-IN-62 inhibits the aggregation of Aβ1-42 with an IC50 of 44.64 μM. This compound also acts as an effective multi-target-directed ligand (MTDL) and is applicable in Alzheimer's disease research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | AChE-IN-62 (Compound 1) is a potent, mixed-type selective inhibitor of acetylcholinesterase (AChE) with an IC50 value of 0.421 μM. It effectively penetrates the blood-brain barrier and offers neuroprotective effects. Additionally, AChE-IN-62 inhibits the aggregation of Aβ1-42 with an IC50 of 44.64 μM. This compound also acts as an effective multi-target-directed ligand (MTDL) and is applicable in Alzheimer's disease research. |
| In vitro | AChE-IN-62 effectively inhibits the aggregation of Aβ 1−42 with an IC50 value of 44.64 μM when used at a concentration of 50 μM for 24-48 hours. Additionally, at concentrations ranging from 5-20 μM over 24 hours, AChE-IN-62 demonstrates neuroprotective properties by mitigating neurotoxicity mediated by H2O2 (200 μM; 24 h) and Okadaic acid (30 nM; 24 h) in SH-SY5Y and Neuro2A cells. |
| In vivo | AChE-IN-62 (Compound 1) at doses of 10-20 mg/kg, administered intraperitoneally once daily for 7 consecutive days, mitigates scopolamine-induced (3 mg/kg; intraperitoneal; once daily for 7 days) memory impairment and learning deficits in Swiss albino mice by repairing damage to the cerebral cortex and hippocampus, thereby offering neuroprotection against scopolamine-induced injuries. |
| Formula | C19H21N5O3S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.